Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine (Q24548001)

6 July 2017

Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine (English)

1 reference

6 July 2017

arterial hypertension

1 reference

Jerie P

1

1 reference

PubMed ID

6994770

6 July 2017

language of work or name

English

0 references

publication date

1 January 1980

1 reference

British Journal of Clinical Pharmacology

6 July 2017

1 reference

6 July 2017

10 Suppl 1

1 reference

6 July 2017

157S-164S

1 reference

Side Effects of Hypotensive Agents Evaluated by a Self-administered Questionnaire

6 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430125

Clinical and biological manifestations following the interruption of prolonged treatment with clonidine

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430125

Guanfacine: effects of long-term treatment and withdrawal

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430125

Clonidine withdrawal. Mechanism and frequency of rebound hypertension

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430125

Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430125

Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430125

Clonidine versus methyldopa. A double blind cross-over study comparing side effects of clonidine and methyldopa administered together with chlorthalidone at a dosage producing the same blood pressure lowering effect

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430125

Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430125

The over-shoot phenomenon on withdrawal of clonidine therapy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430125

Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1980.TB04924.X

Clinical experience with guanfacine in long-term treatment of hypertension

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1980.TB04924.X

Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1980.TB04924.X

Antihypertensive effect of a new imidazoline compound (clonidine) and chlorthalidone, individually and in combination

21 January 2018

1 reference

12 December 2020

First experiences with BS 100-141, a new antihypertensive substance

1 reference

12 December 2020

Blood pressure and heart rate and withdrawal of antihypertensive drugs

1 reference

12 December 2020

Abrupt cessation of clonidine administration: a prospective study

1 reference

12 December 2020

10.1111/J.1365-2125.1980.TB04924.X

Identifiers

DOI

1 reference

6 July 2017

1 reference

6 July 2017

1 reference

PubMed ID

6994770